Rhenman & Partners Asset Management’s Agilon Health AGL Stock Holding History

Rhenman & Partners Asset Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$536K	Buy	+5,000	New	+$327K	0.05%	96
2023 Q2	–	Sell	-3,600	Closed	-$2.1M	–	84
2023 Q1	$2.1M	Sell	3,600 -6,600	-65%	-$3.7M	0.23%	76
2022 Q4	$4.12M	Hold	10,200	–	–	0.43%	66
2022 Q3	$5.06M	Buy	10,200 +3,600	+55%	+$2.16M	0.53%	58
2022 Q2	$3.6M	Buy	+6,600	New	+$3.34M	0.41%	64

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rhenman & Partners Asset Management's AGL Position: Q2 2026 in Review

Rhenman & Partners Asset Management opened a new position in Agilon Health (AGL) in Q2 2026: 5,000 shares worth $536K. The stake represents 0.05% of the portfolio and ranks #96 among its holdings. This is a return to the name: Rhenman & Partners Asset Management previously reported a position in AGL as recently as Q1 2023.

Rhenman & Partners Asset Management first reported a position in AGL in Q2 2022 and has held it in 5 quarters since. The position peaked at $5.06M in Q3 2022. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Rhenman & Partners Asset Management held 5,000 shares of Agilon Health worth $536K as of Q2 2026.
Agilon Health was a new Rhenman & Partners Asset Management position in Q2 2026.
Agilon Health made up 0.05% of Rhenman & Partners Asset Management's portfolio in Q2 2026, its #96 holding.
Rhenman & Partners Asset Management first reported a position in Agilon Health in Q2 2022 and has held it in 5 quarters since.
Rhenman & Partners Asset Management's Agilon Health position peaked at $5.06M in Q3 2022.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.